BG Medicine (BGMD) Misses Q1 EPS by 1c

BG Medicine (NASDAQ: BGMD) reported Q1 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $437 thousand versus the consensus estimate of $1.6 million.

For earnings history and earnings-related data on BG Medicine (BGMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c